Biotechnology Company
Appears in 1 story
Advancing oral metabolic accelerator with fat-specific weight loss in Phase 2
The biggest knock against blockbuster weight-loss drugs like semaglutide is that up to 40% of weight lost is lean tissue (muscle and bone), not fat. New therapies entering trials target genes to spare muscle.
Updated May 30
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
